Personalized Therapy and Clinical Outcome for Vasculitis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology & Rheumatology".
Deadline for manuscript submissions: 25 August 2026 | Viewed by 1
Special Issue Editor
Interests: rheumatology and immunology; autoimmune diseases; vasculitis; SLE; connective tissue diseases; interstitial lung disease; rheumatoid arthritis; capillaroscopy; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Systemic vasculitides are a heterogeneous group of immune-mediated diseases characterized by inflammation of blood vessels, leading to tissue ischemia, organ dysfunction, and significant morbidity. They are traditionally classified according to the size of the affected vessels into small, medium, or large vessel vasculitis. Although many forms are rare, they often present with severe, life-threatening manifestations and multi-organ involvement, requiring complex clinical management. Despite advances in classification and therapeutic strategies, the management of vasculitis remains challenging. The heterogeneity of clinical presentation, the lack of robust biomarkers of disease activity, and the frequent need for multidisciplinary care complicate treatment decisions. Conventional immunosuppressive regimens have improved survival, but relapses, treatment-related toxicity, and incomplete disease control are still common. In recent years, the concept of personalized therapy has gained increasing relevance. Advances in immunopathogenesis, the identification of novel biomarkers, and the integration of imaging and genetic/epigenetic data have paved the way for individualized treatment strategies. Tailoring therapy to disease subsets, serological profiles, and patient characteristics holds promise for optimizing efficacy while minimizing adverse effects. Equally important is the evaluation of long-term clinical outcomes, including organ damage, quality of life, and treatment sustainability, which are essential to guide therapeutic decisions. This Special Issue, entitled “Personalized Therapy and Clinical Outcome for Vasculitis”, aims to provide a comprehensive overview of current knowledge and future perspectives in the field. Contributions will address innovative therapeutic approaches, prognostic markers, and outcome measures, highlighting the potential of personalized medicine to transform clinical practice. By integrating translational research with real-world clinical data, this collection seeks to advance our understanding of vasculitis and support the development of individualized management pathways that improve patient outcomes.
Dr. Giulia Cassone
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune-mediated systemic vasculitis
- personalized therapy
- treatment
- outcome
- biomarkers
- risk factors
- management
- multidisciplinary care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
